Cite
HARVARD Citation
Li, Y. et al. (n.d.). 1123. EDP-235, A Potent and Once-daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes, with the Potential for Mitigation of Cytokine Storm in High-Risk COVID-19 Patients. Open forum infectious diseases. p. . [Online].